181 related articles for article (PubMed ID: 16296572)
1. Quality of life and antihypertensive effect with nebivolol and losartan.
Van Bortel LM; Bulpitt CJ; Fici F
Am J Hypertens; 2005 Aug; 18(8):1060-6. PubMed ID: 16296572
[TBL] [Abstract][Full Text] [Related]
2. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
Weiss RJ; Stapff M; Lin Y
Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of nebivolol compared with other antihypertensive drugs: a meta-analysis.
Van Bortel LM; Fici F; Mascagni F
Am J Cardiovasc Drugs; 2008; 8(1):35-44. PubMed ID: 18303936
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
Giles TD; Weber MA; Basile J; Gradman AH; Bharucha DB; Chen W; Pattathil M;
Lancet; 2014 May; 383(9932):1889-98. PubMed ID: 24881993
[TBL] [Abstract][Full Text] [Related]
5. Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life.
Van Bortel LM; Breed JG; Joosten J; Kragten JA; Lustermans FA; Mooij JM
J Cardiovasc Pharmacol; 1993 Jun; 21(6):856-62. PubMed ID: 7687708
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
Germino FW
Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacy and tolerability of nebivolol versus lisinopril in the treatment of essential arterial hypertension: a randomized, multicentre, double-blind study.
Rosei EA; Rizzoni D; Comini S; Boari G;
Blood Press Suppl; 2003 May; 1():30-5. PubMed ID: 12800985
[TBL] [Abstract][Full Text] [Related]
8. Nebivolol versus nifedipine in the treatment of essential hypertension: a double-blind, randomized, comparative trial.
Van Nueten L; Lacourcière Y; Vyssoulis G; Korlipara K; Marcadet DM; Dupont AG; Robertson JI
Am J Ther; 1998 Jul; 5(4):237-43. PubMed ID: 10099065
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations.
Gambarin FI; Favalli V; Serio A; Regazzi M; Pasotti M; Klersy C; Dore R; Mannarino S; Viganò M; Odero A; Amato S; Tavazzi L; Arbustini E
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):354-62. PubMed ID: 19430350
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.
Brixius K; Middeke M; Lichtenthal A; Jahn E; Schwinger RH
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):327-31. PubMed ID: 17324145
[TBL] [Abstract][Full Text] [Related]
11. β-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial.
Espinola-Klein C; Weisser G; Jagodzinski A; Savvidis S; Warnholtz A; Ostad MA; Gori T; Munzel T
Hypertension; 2011 Aug; 58(2):148-54. PubMed ID: 21646599
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.
Papademetriou V
Am J Cardiol; 2009 Jan; 103(2):273-8. PubMed ID: 19121451
[TBL] [Abstract][Full Text] [Related]
13. [Nebivolol, a beta blocker of the 3rd generation: modern therapy of arterial hypertension. Results of a multicenter observation study].
von Fallois J; Faulhaber HD
Praxis (Bern 1994); 2001 Mar; 90(11):435-41. PubMed ID: 11293936
[TBL] [Abstract][Full Text] [Related]
14. Treatment of ambulatory hypertensives with nebivolol or hydrochlorothiazide alone and in combination. A randomized, double-blind, placebo-controlled, factorial-design trial.
Lacourcière Y; Lefebvre J; Poirier L; Archambault F; Arnott W
Am J Hypertens; 1994 Feb; 7(2):137-45. PubMed ID: 8179848
[TBL] [Abstract][Full Text] [Related]
15. [Prospective follow-up of nebivolol in the treatment of arterial hypertension].
Despotović N; Matić-Cvetković D; Ivanović B
Srp Arh Celok Lek; 2012; 140(7-8):425-30. PubMed ID: 23092025
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes.
Fogari R; Zoppi A; Lazzari P; Mugellini A; Lusardi P; Preti P; Van Nueten L; Vertommen C
J Hum Hypertens; 1997 Nov; 11(11):753-7. PubMed ID: 9416986
[TBL] [Abstract][Full Text] [Related]
17. Nebivolol: a third-generation beta-blocker for hypertension.
Cheng JW
Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
[TBL] [Abstract][Full Text] [Related]
18. Comparison of antihypertensive and beta 1-adrenoceptor antagonist effect of nebivolol and atenolol in essential hypertension.
Simon G; Johnson ML
Clin Exp Hypertens; 1993 May; 15(3):501-9. PubMed ID: 8098243
[TBL] [Abstract][Full Text] [Related]
19. Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.
Pesant Y; Marc-Aurèle J; Bielmann P; Alaupovic P; Cartier P; Bichet D; Thibault G; Lupien PJ
Am J Ther; 1999 May; 6(3):137-47. PubMed ID: 10423656
[TBL] [Abstract][Full Text] [Related]
20. Comparative assessment of antihypertensive efficacy of DL-nebivolol and D-nebivolol in patients with confirmed mild to moderate hypertension.
Lacourcière Y; Poirier L; Lefebvre J; Archambault F; Cléroux J
J Cardiovasc Pharmacol; 1995 Apr; 25(4):619-24. PubMed ID: 7596131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]